Home Stocks Novartis India Ltd

Novartis India Ltd

The live share price of Novartis India Ltd (NOVARTIND) as on 15 Apr 9:59am is ₹1,030.1 from NSE/BSE.

NOVARTIND NSE

₹1,030.1 ▼-1.52% (-15.95)

As on Apr 15, 2024 03:29 PM IST

How do you feel today about Novartis India Ltd?

Key Metrics

PE Ratio

27.04

PB Ratio

3.33

Dividend Yield

4.54%

Sector PB

1.44

Sector PE

-43.33

Sector Div Yld

0.17%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

sec-img

Sector

sec-img

Industry

sec-img

Market Cap

Smallcap, ₹2,582 Cr

Novartis India Limited manufactures drugs, medicines and allied products. The Company is engaged in the wholesale of pharmaceuticals and medical goods.

The following charts display the financial performance of the Novartis India Ltd (NOVARTIND) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Novartis India Ltd (NOVARTIND), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

sec-img

Sector

sec-img

Industry

sec-img

Market Cap

Smallcap, ₹2,582 Cr

Financials

Income Statement

(INR) Y/Y Change
Revenue 436 Cr +0.88%
Operating Expense 28 Cr -62.3%
Net Income 103 Cr -2878.49%
Net Profit Margin 23.66% -2851.16%
Earning Per Share 41 -2878.38%
EBITDA 123 Cr +1055.63%

Balance sheet

(INR) Y/Y Change
Cash & short-term Inv 555 Cr +7.4%
Total Assets 982 Cr +2.65%
Total Liabilities 207 Cr -22.04%
Total Equity 775 Cr +12.14%
Shares Outstanding 2.47 Cr +0.04%
Price to Book 1.79 -19.25%
Return on Assets 10.65% -2902.63%
Return on Capital 15.1 Cr +9966.67%

Cash Flows

(INR) Y/Y Change
Net Income 103 Cr -2878.49%
Cash from Operations 44 Cr +15.85%
Cash from Investing -153 Cr -276.07%
Cash from Financing -30 Cr -14.45%
Net Change in Cash -138 Cr -254.23%
Free Cash Flow 44 Cr +16.56%
Total Promoter Holding
70.68%
Unpledged
Foreign Institutions
0.19%
Foreign Institutions
Retail & Others
28.59%
Retail & Others
Other Parties
Other Domestic Institutions
0.53%
Insurance Firms
Others
Mutual Funds
0%
Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

41.49

1Y Return

▲54.2%

CIPLA

Cipla Ltd

PE Ratio

30.41

1Y Return

▲54.1%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

19.38

1Y Return

▲25.38%

ZYDUSLIFE

Zydus Lifesciences Ltd

PE Ratio

32.56

1Y Return

▲91.63%

Latest News

latest-news

RMI Scanner generates new ‘buy’ signal in these 4 stocks; do you own any?

2 months ago on Moneycontrol

Change since news ▼-INF%

We saw small caps outperform the key benchmark indices. MRPL was the top small cap gainer, up by 19.23 percent. JBMA, BF Utilities, Novartis India and Hitech Pipes each gained by more than 15 percent.


latest-news

What Dr. Reddy’s Stands To Gain From Buying Novartis’ India Business

2 months ago on Bloomberg Quint

Change since news ▼-INF%

Novartis India’s brands could complement Dr Reddy’s existing presence in those segments, according to Nomura.


latest-news

Dr. Reddy’s Hits Life High On Reports Of Acquiring Novartis India

2 months ago on Bloomberg Quint

Change since news ▼-INF%

Novartis AG has commenced the strategic review that will include an assessment of its 70.68% shareholding in the India unit.


latest-news

Is Novartis Planning To Sell Its India Unit?

2 months ago on Bloomberg Quint

Change since news ▼-INF%

Media reports suggest that drugmaker Dr. Reddy’s Laboratories Ltd. is in the race to acquire the Novartis AG’s stake in Novartis India.


latest-news

Dr. Reddy’s eyeing to acquire Novartis’ India arm: Report

2 months ago on Moneycontrol

Change since news ▼-INF%

Novartis India, a listed entity, is set to undergo an assessment encompassing various aspects, including its parent Novartis AG’s 70.68% shareholding.


FAQs on Novartis India Ltd

How to buy Novartis India Ltd stocks?

You can easily buy the stocks/shares of Novartis India Ltd (NOVARTIND) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Novartis India Ltd?

The stock price of Novartis India Ltd as on 15 Apr 2024 is ₹1,030.1

What is the 52-week High and Low of Novartis India Ltd?

The 52-week high and low of Novartis India Ltd (NOVARTIND) is ₹1,224 and ₹574.

What is the PE and PB ratio of Novartis India Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Novartis India Ltd are 27.04 and 3.33 respectively.

What are the peers or stocks similar to Novartis India Ltd?

The peers or stocks similar to Novartis India Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Zydus Lifesciences Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Novartis India Ltd belong to?

Novartis India Ltd (NOVARTIND) belongs to the Pharmaceuticals sector.

What is the Market Cap of Novartis India Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Novartis India Ltd (NOVARTIND) is ₹2,582 Cr as of 15 Apr 2024

Can't decide whether or not to buy Novartis India Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.